Texas abortion drug ruling could create ‘slippery slope’ for FDA approvals, drug research and patients, experts say
What happened in one judge’s courtroom in Texas could have drastic effects for the United States’ entire drug approval process, experts District Judge Matthew Kacsmaryk’s ruling that suspended the Food and Drug Administration’s approval of the medication abortion…
Read More